Sakar Healthcare has signed an agreement with Zydus Life Sciences (Cadila Healthcare) to manufacture Oncology products. Zydus has shown their confidence by initiating processes to manufacture their anticancer range of products at Sakar's State-of-the Art facility. The technology transfer and product know-how have been shared with technical team of Sakar to initiate the process. The relevant product APls and other raw materials have reached the site for which process validation, stability and qualification have been initiated.
On completion further pilot batches will be taken up for each of the formulations followed by commercial productions. Thus the vertically integrated research-API-manufacturing set-up is well set for delivering products in oncology range with Zydus Life Sciences (Cadila Healthcare) showing the trust and leading the way.
Sakar Healthcare is an Indian pharmaceutical company engaged in the manufacturing and marketing of its own pharmaceutical formulations for domestic and international markets.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1807.25 |
| Dr. Reddys Lab | 1273.90 |
| Cipla | 1388.80 |
| Zydus Lifesciences | 1104.35 |
| Lupin | 2292.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: